Treatment Options and Antifungal Resistance in Pediatric Candidozyma auris (Previously Candida auris) Infections: A Systematic Review of Clinical Outcomes
Microorganisms · 19.01.2026 · 14 (1) · 228
DOI: 10.3390/microorganisms14010228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 19.01.2026. Verfasst von Konstantinos Stergiou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Team "Histologistas", Interinstitutional Postgraduate Program "Health and Environmental Factors", School of Medicine, Faculty of Health Scie…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candidozyma auris (previously named Candida auris) has been recognized as a significant public health threat due to its extensive transmission in hospital settings, high mortality rates, and multidrug resistance. Evidence regarding optimal antifungal treatment in children remains limited. The present systematic review aims to synthesize available evidence on pediatric C. auris infections, focusing on antifungal treatment, resistance profiles, and clinical outcomes. A systematic search was conducted across PubMed, Scopus, and Web of Science, identifying case reports and case series of pediatric patients with confirmed C. auris infection. Data were extracted on demographics, comorbidities, infection site, antifungal therapy, and outcomes. Risk of bias was assessed using JBI Critical Appraisal checklists. Fourteen studies comprising 62 patients were included, with most cases being bloodstream infections. C. auris showed widespread fluconazole resistance and variable susceptibility to amphotericin B. Echinocandins were the most commonly used agents, generally associated with survival. Overall mortality was 35%, similar to that reported for adults. Combination therapy showed numerically higher survival, although given the small sample size and heterogeneity of treatment regimens, no comparative inferences can be made. Pediatric C. auris infections mirror adult patterns of antifungal resistance and mortality. Echinocandins remain first line therapy; however, the emergence of echinocandin resistance underscores the urgent need for antifungal stewardship, standardized pediatric guidelines, and novel antifungal development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Team "Histologistas", Interinstitutional Postgraduate Program "Health and Environmental Factors", School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Laboratory of Histology-Embryology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Department of Neurology, Agios Pavlos General Hospital of Thessaloniki, Leoforos Ethnikis Antistaseos 161, Kalamaria, 55134 Thessaloniki, Greece.
- Laboratory of Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Third Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.
- Pediatric & Adolescent Hematology Oncology Unit, 2nd Pediatric Department, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA Hospital, 54124 Thessaloniki, Greece.
ORCID-Profile: Konstantinos Stergiou, Kanellos Skourtsidis, Georgios Kiosis, Despoina Ioannou, Vasilis-Spyridon Tseriotis, Vasileios Fouskas, Sofia Karachrysafi, Elias Iosifidis, Emmanuel Roilides, Theodora Papamitsou, Maria Kourti
Zitieren
APA
Stergiou, K., Skourtsidis, K., Kiosis, G., Ioannou, D., Tseriotis, V. S., Fouskas, V., Karachrysafi, S., Iosifidis, E., Roilides, E., Papamitsou, T., & Kourti, M. (2026). Treatment Options and Antifungal Resistance in Pediatric Candidozyma auris (Previously Candida auris) Infections: A Systematic Review of Clinical Outcomes. Microorganisms, 14(1), 228. https://doi.org/10.3390/microorganisms14010228
Vancouver
Stergiou K, Skourtsidis K, Kiosis G, Ioannou D, Tseriotis VS, Fouskas V, et al. Treatment Options and Antifungal Resistance in Pediatric Candidozyma auris (Previously Candida auris) Infections: A Systematic Review of Clinical Outcomes. Microorganisms. 2026;14(1):228. doi:10.3390/microorganisms14010228
BibTeX
@article{Stergiou2026,
author = {Stergiou, Konstantinos and Skourtsidis, Kanellos and Kiosis, Georgios and Ioannou, Despoina and Tseriotis, Vasilis-Spyridon and Fouskas, Vasileios and Karachrysafi, Sofia and Iosifidis, Elias and Roilides, Emmanuel and Papamitsou, Theodora and Kourti, Maria},
title = {Treatment Options and Antifungal Resistance in Pediatric Candidozyma auris (Previously Candida auris) Infections: A Systematic Review of Clinical Outcomes},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {1},
pages = {228},
doi = {10.3390/microorganisms14010228}
}
EUVIMED